Cross-linking of surface IgM or IgD B-cell receptors (BCR) with appropriate
anti-Ig antibodies induces IgM(high) or IgD(high) B-cell depletion, respec
tively. The aim of this paper is to analyze how injections of anti-delta fo
llowed by anti-mu monoclonal antibodies (mAb) can deplete and suppress B ce
lls and then induce T-independent type 2 antigen tolerance in adult mice ev
en after treatment is stopped. The experimental protocol consisted of three
daily injections of anti-6 mAb followed by repeated injections of anti-p m
Ab. It shows that a sequential injection of anti-6 and anti-mu mAb induces
B-cell depletion and T-independent type 2 response downregulation. Morever,
the T-dependent response is maintained, except for the IgG3 isotype. After
clearance of the anti-6 mAb from the circulation, B cells reappear as an I
gD(+) IgM(-) B-cell population in the bone marrow (BM) and spleen. The orig
in of IgD(+) IgM(-) cells was studied in scid mouse transfer models. We sho
w that IgD(+) IgM- B cells are not mature cells reexpressing sIgD but BM-de
rived cells that require a T-cell presence to be developed. The lack of sIg
M expression by posttranscriptional regulation and the need of T-cell help
for escaping anti-mu negative selection suggest strongly that this populati
on had properties similar to those of anergized B cells. These results supp
ort the potential use of sequential injections of anti-delta and anti-mu in
the prevention of xenograft rejection. (C) 2000 Academic Press.